World Cancer Research Day 2026
September 24, 2026
2026 Press Conference: Clinical Research in Switzerland Under Pressure
The number of clinical trials in Switzerland is declining. This has implications not only for patients, who are consequently less likely to gain early access to innovative therapies, but also for the country as a business hub and its research ecosystem.
To mark World Cancer Research Day, the Swiss Cancer Institute and Interpharma are highlighting why studies are increasingly being conducted abroad and what it will take for Switzerland to regain its position as a leading research hub. The focus is on three key areas: streamlined processes, sustainable funding for independent academic research, and a national health data repository.
The press release and additional background information are available for download below.
-
Vincent Gruntz
Chief Executive Officer
-
René Buholzer
Chief Executive Officer Interpharma
-
Lea Kusano
Chief Communication & Strategic Partnership Officer